ABSTRACT
INTRODUCTION
Ventricular late potential [VLP] (1-6) is the high-frequency low-amplitude cardiac potential that appears at the end of the QRS complex and extends to the ST segment. It is the manifestation of delayed depolarization in regional myocardium, which is the main factor that leads to re-entrant ventricular Ventricular Late Potential in Acute STEMI and STEMI Patients tachycardia. In recent years, the detection and clinical significance of VLP in coronary artery disease patients has received more attention, especially the significance of ventricular arrhythmia prediction in acute myocardial infarction patients. However, there was no research about the clinical features of VLP between patients with acute ST-segment elevation myocardial infarction (STEMI) and patients with acute non STEMI. Thus, the objective of this paper is to discuss the positive rate of VLP between STEMI patients and NSTEMI patients.
SUBJECTS AND METHODS
Research subjects were randomly recruited between June 2011 and August 2011 from inpatients at the Department of Cardiology of the First Hospital of China Medical University (Shenyang, China). The patients were included if they presented with a new-onset acute myocardial infarction (AMI), defined as having typical chest pain of > 30 minutes duration or electrocardiogram (ECG) changes compatible with AMI, or both, and total serum creatine-kinase levels at least twice the upper limit of normal range with abnormal creatine kinase-MB or troponin levels. Patients who met any of the following criteria were excluded: past history of myocardial infarction, left or right bundle-branch block, intraventricular conduction abnormalities (QRS duration > 120 milliseconds) and if the patient refused to undergo VLP examination.
A total of 186 AMI patients met the inclusion criteria, but 23 of these also met one or more exclusion criteria and were excluded, including 11 patients who had past history of myocardial infarction, seven patients who had left or right bundle-branch block, one patient with intraventricular conduction abnormalities and four patients who refused to undergo VLP examination. Thus, a total of 163 AMI patients were included as subjects in this study.
The 163 cases of AMI patients were divided into STEMI group and NSTEMI group according to whether the ST segment was raised: 90 cases were in the STEMI group, and 73 cases in the NSTEMI group. All 163 cases underwent VLP examination. The occurrences of ventricular arrhythmia (ventricular fibrillation, ventricular flutter and sustained ventricular tachycardia) were determined by continuous ECG monitoring.
The study was approved by the Ethics Committee of China Medical University. Participants signed a written consent form before participating.
Measurement of VLP obtained from signal-averaged ECG
Signal-averaged electrocardiogram (SAECG) was analysed using a signal-averaged ECG system (MAC 5500 Resting ECG Analysis System, made by General Electric Company). The quantitative time domain mode with the filtered vector magnitude of the orthogonal Frank x, y, and z leads were used to measure VLPs, with frequency cut-off between 40 and 250 Hz. Approximately 200 beats were filtered and averaged. The noise level was controlled below 0.4 µV. Three quantitative parameters of SAECG were considered to assess the presence of VLPs using a computer algorithm: (i) the filtered QRS duration (f-QRS) of 114 milliseconds or more; (ii) the duration of the low-amplitude signal (LAS) of < 40 µV in the terminal portion of the filtered QRS complex of 38 milliseconds or more and (iii) the root mean square (RMS) voltage of the terminal 40 millisecond of the filtered QRS of 20 µV or less. Ventricular late potentials were present when at least two of these showed abnormal values (1, 5) .
Statistical analysis
The positive rate of VLP and the occurrence rate of malignant ventricular arrhythmia were treated as enumeration data. The comparison between STEMI and NSTEMI groups was calculated by Chi-squared test, using SPSS 19.0 software. A pvalue of < 0.05 was considered statistically significant.
RESULTS

Characteristics of patients
Of the 90 STEMI patients (STEMI group), 57 patients were male, and 33 patients were female. The mean age of the STEMI group was 61.6 ± 12.4 years. Of the 73 NSTEMI patients (NSTEMI group), 53 patients were male, and 20 patients were female. The mean age of the NSTEMI group was 63.5 ± 13.1 years (Table 1) . Of 77 VLP positive patients, nine patients had ventricular arrhythmia, while of 86 VLP negative patients, three patients had ventricular arrhythmia. The occurrence rate of ventricular arrhythmia in VLP positive patients was 11.7%, while in VLP negative patients it was 3.5% [χ 2 = 4.005, p < 0.05] ( Table 3) . extends through the full thickness of the cardiac wall, thus we speculate this might be the reason why the VLP positive rate of the STEMI group is higher than that of the NSTEMI group, and it needs further study.
Ventricular late potentials reflect the presence of slow conduction within the ventricular myocardium that may serve as a substrate for arrhythmogenesis (5) (6) (7) (8) (9) . In the present study, the occurrence rate of ventricular arrhythmia in VLP positive patients is higher than that in VLP negative patients, and VLP is one of the important indicators to predict the ventricular arrhythmia attack in acute myocardial infarction patients. Therefore, close attention should be paid to the patients with VLP positive myocardial infarction and continuous ECG monitoring should be used promptly as well as treatment started early in order to reduce the occurrence of ventricular arrhythmia. The process of averaging QRS complexes reduces these non-cardiac signals without modifying VLPs, and the SAECG is a specialized ECG which reveals the presence of VLPs by reducing the random noise. The value of VLP that is closely related to sudden death as an independent factor to predict the malignant arrhythmia events after myocardial infarction is widely recognized (1-7). Ventricular late potential exists in the border zone between normal tissue and necrotic scar tissue of myocardial infarction patients. A slow conduction "channel" has been reported to be frequently found in the viable myocardium that is bordered by such necrotic scar tissue. The nonconductive ventricular scar and the "channel" are the mechanisms that create the occurrence of lethal ventricular arrhythmias (8) . In the present study, the VLP positive rate of the STEMI group is higher than that of the NSTEMI group, and the differences are statistically significant. In STEMI patients, the infarction is "transmural" in that it
